© Copyright Bhekisisa Centre for Health Journalism | Privacy Policy | Terms and Conditions | PAIA Manual
OUR LATEST POSTS
SA gets R520-million to buy the twice-a-year anti-HIV jab — but there’s a snag
SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year anti-HIV jab, lenacapavir. Research shows the shot could help end Aids in the country. But there’s a snag.
Making diphtheria great again? Why SA’s public health experts are worried about RFK Jr
Misinformation fuelled by US health czar Robert Kennedy Jr is creating a dangerous — and growing — lack of trust in vaccines. Here’s why South Africa’s public health experts are scared.
If your cigarette box isn’t disgusting, it’s not doing its job
A throat ulcer. Bloody urine. A sick baby. That’s what smokers in other countries see. In South Africa? For now, it’s a tiny black box.
Here’s the drinking conversation we need to have
Telling most South Africans they can’t drink is a nonstarter. But what we all do need to know is just how dangerous it is — and what we can do to curb it.
Health Beat #31 | Can South Africa’s HIV fight survive the US funding pull-out?
Articles
Anna-Maria van Niekerk, Mia Malan, Jessica Pitchford, Yolanda Mdzeke, Thatego Mashabela and Justin Barlow -
South Africa’s HIV programme is the biggest in the world, but now it’s been cut thin, with the loss of billions in US funding. Health economists warn of a surge in new infections and deaths if South Africans forgo their treatment. Could an expensive HIV jab be the answer?
Professor screw it, let’s do it
Francois Venter, a big rock climber, once drank tequila with the PhD-holding virologist rockstar Dexter Holland of The Offspring and, more recently, publicly excoriated both the president and the health minister for their inaction on the HIV funding crises. As Sean Christie quickly learned, that’s just how one of the country’s top HIV researchers rolls.